180 related articles for article (PubMed ID: 10543484)
1. Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study.
Wan S; LeClerc JL; Antoine M; DeSmet JM; Yim AP; Vincent JL
Ann Thorac Surg; 1999 Oct; 68(4):1230-5. PubMed ID: 10543484
[TBL] [Abstract][Full Text] [Related]
2. Steroid administration in heart and heart-lung transplantation: is the timing adequate?
Wan S; DeSmet JM; Antoine M; Goldman M; Vincent JL; LeClerc JL
Ann Thorac Surg; 1996 Feb; 61(2):674-8. PubMed ID: 8572786
[TBL] [Abstract][Full Text] [Related]
3. Effects of two differently heparin-coated extracorporeal circuits on markers for brain and myocardial dysfunction.
Flom-Halvorsen HI; Ovrum E; Brosstad F; Tangen G; Ringdal M; Oystese R
Perfusion; 2002 Sep; 17(5):339-45. PubMed ID: 12243437
[TBL] [Abstract][Full Text] [Related]
4. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction.
Heyer EJ; Lee KS; Manspeizer HE; Mongero L; Spanier TB; Caliste X; Esrig B; Smith C
J Cardiothorac Vasc Anesth; 2002 Feb; 16(1):37-42. PubMed ID: 11854876
[TBL] [Abstract][Full Text] [Related]
5. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
7. Heparin coating of extracorporeal circuits inhibits cytokine release from mononuclear cells during cardiac operations.
Giomarelli P; Naldini A; Biagioli B; Borrelli E
Int J Artif Organs; 2000 Apr; 23(4):250-5. PubMed ID: 10832659
[TBL] [Abstract][Full Text] [Related]
8. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
10. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
[TBL] [Abstract][Full Text] [Related]
12. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass.
Itoh H; Ichiba S; Ujike Y; Douguchi T; Kasahara S; Arai S; Sano S
Perfusion; 2016 Apr; 31(3):247-54. PubMed ID: 26228276
[TBL] [Abstract][Full Text] [Related]
14. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
[TBL] [Abstract][Full Text] [Related]
15. Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery.
Olsson C; Siegbahn A; Henze A; Nilsson B; Venge P; Joachimsson PO; Thelin S
Scand Cardiovasc J; 2000; 34(1):33-40. PubMed ID: 10816058
[TBL] [Abstract][Full Text] [Related]
16. Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated extracorporeal circuits. A clinical pilot study.
Bouma M; Maessen J; Weerwind P; Dentener M; Fransen E; de Jong D; Buurman W
Chest; 1997 Mar; 111(3):577-83. PubMed ID: 9118690
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
19. Effects of Duraflo II heparin-coated cardiopulmonary bypass circuits on the coagulation system, endothelial damage, and cytokine release in patients with cardiac operation employing aprotinin and steroids.
Inui K; Shimazaki Y; Watanabe T; Takahashi T; Minowa T; Takeda H; Yanagawa N; Sotoda Y
Artif Organs; 1999 Dec; 23(12):1107-12. PubMed ID: 10619929
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery.
Deptula J; Glogowski K; Merrigan K; Hanson K; Felix D; Hammel J; Duncan K
J Extra Corpor Technol; 2006 Mar; 38(1):22-6. PubMed ID: 16637519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
